Supplemental material
Open access
1,481
Views
1
CrossRef citations to date
0
Altmetric
Neurology
Defining utility values for patients with tardive dyskinesia
Rajeev Ayyagaria Analysis Group, Inc, Boston, MA, USACorrespondence[email protected]
https://orcid.org/0000-0003-0870-2309
Debbie Goldschmidtb Analysis Group, Inc, New York, NY, USA
https://orcid.org/0000-0002-8334-2211
Mo Zhoua Analysis Group, Inc, Boston, MA, USA
, Rinat Ribalovc Teva Pharmaceuticals, Tel Aviv, Israel
, Stanley N. Caroffd Department of Psychiatry, Michael J. Crescenz VA Medical Center and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
https://orcid.org/0000-0003-2840-4763
Sam Leoe Teva Pharmaceuticals, Parsippany, NJ, USA
Pages 401-407
|
Received 18 Nov 2021, Accepted 22 Dec 2021, Published online: 21 Jan 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.